Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Neurodegeneration Stories

2013-06-10 11:17:57

First in vivo study of the treatment for this condition shows significant physical improvement The group of genetic conditions known as spinocerebellar ataxias currently have no treatment or cure and are always fatal, in the case of affected children at an early age. Symptoms include a progressive lack of co-ordination of gait, and poor co-ordination of hands, speech and eye movements, due to a failure of co-ordination of muscle movements. Now researchers from France and the US have found...

Alzheimer's Disease Protection From Compounds In Cinnamon
2013-05-24 05:11:40

redOrbit Staff & Wire Reports - Your Universe Online Two compounds found in cinnamon could play a role in delaying the onset of Alzheimer´s disease, and could even prevent the neurodegenerative condition, according to new research published online in The Journal of Alzheimer's Disease on Thursday. The study authors, Roshni George and Donald Graves of the University of California, Santa Barbara (UCSB), explained that the compounds cinnamaldehyde and epicatechin have shown...

2013-05-10 11:57:50

Researchers at Georgetown University Medical Center have used tiny doses of a leukemia drug to halt accumulation of toxic proteins linked to Parkinson's disease in the brains of mice. This finding provides the basis to plan a clinical trial in humans to study the effects. They say their study, published online May 10 in Human Molecular Genetics, offers a unique and exciting strategy to treat neurodegenerative diseases that feature abnormal buildup of proteins in Parkinson's disease,...

2013-05-10 11:45:18

Research opens door to new drug therapies for Parkinson´s disease McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson´s disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The Neuro, and  Dr. Kalle Gehring  in the Department of Biochemistry at the Faculty of Medicine, have discovered the three-dimensional structure of the protein Parkin. Mutations in Parkin...

2013-05-06 08:30:03

--After Successful Pre-IND Meeting, Company On Track to Advance Lead Compound NPT002 into Clinical Trials for Alzheimer's Disease in 2014-- CAMBRIDGE, Mass., May 6, 2013 /PRNewswire/ -- NeuroPhage Pharmaceuticals, Inc., a company developing breakthrough therapies for neurodegenerative diseases, today announced that it raised $6.4 million in a private equity financing round. Merieux Developpement led the financing with participation from all current Neurophage investors, including...

2013-04-30 14:18:23

Research published in the May 2013 journal GENETICS may shed light on the root cause of some neurodegenerative diseases Scientists have identified a gene that keeps our nerve fibers from clogging up. Researchers in Ken Miller's laboratory at the Oklahoma Medical Research Foundation (OMRF) found that the unc-16 gene of the roundworm Caenorhabditis elegans encodes a gatekeeper that restricts flow of cellular organelles from the cell body to the axon, a long, narrow extension that neurons use...

2013-04-26 10:24:16

A protein known to be a key player in the development of Parkinson's disease is able to enter and harm cells in the same way that viruses do, according to a Loyola University Chicago Stritch School of Medicine study. The protein is called alpha-synuclein. The study shows how, once inside a neuron, alpha synuclein breaks out of lysosomes, the digestive compartments of the cell. This is similar to how a cold virus enters a cell during infection. The finding eventually could lead to the...

Alzheimer's Disease: Protective Gene Variant Sheds Light On Potential New Treatment
2013-04-26 04:44:04

redOrbit Staff & Wire Reports - Your Universe Online New research published Thursday in the journal Neuron sheds new light on the molecular causes of Alzheimer´s disease, while also revealing a potential new therapy which could help prevent cognitive decline and brain damage during the early stages of the neurodegenerative disorder. The study focuses on a variant of a gene known as CD33, which typically contributes to Alzheimer´s disease by inhibiting the ability of a...

2013-04-18 21:51:41

Researchers have recently discovered that an expansion of DNA in patients with the common neurodegenerative disorder Fragile X-associated Tremor syndrome causes the production of an abnormal protein that is toxic to neurons. The findings, which are reported online April 18 in the Cell Press journal Neuron, suggest an unexpected process by which DNA expansions might lead to neurodegenerative diseases–including Huntington's disease and ALS. This discovery reveals a common feature among...

2013-04-02 16:25:24

Rockefeller Plaza Exhibit Highlights Hope for the Growing Health Concern NEW YORK, April 2, 2013 /PRNewswire/ -- As the leader for research in ALS, the devastating brain disorder also known as Lou Gehrig's disease, Project A.L.S. has been selected by EHE International to raise awareness about ALS and related brain diseases in a 103-square foot window display in Rockefeller Plaza. The interactive Project A.L.S. exhibit debuts today in the major international thoroughfare, and will be...